Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
152M
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
111M
-
Shares change
-
+10.5M
-
Total reported value, excl. options
-
$5.41B
-
Value change
-
+$508M
-
Put/Call ratio
-
0.32
-
Number of buys
-
130
-
Number of sells
-
-65
-
Price
-
$48.63
Significant Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q3 2020
242 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q3 2020.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 111M shares
of 152M outstanding shares and own 73.27% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (33.5M shares), Matrix Capital Management Company, LP (13.1M shares), VANGUARD GROUP INC (7.07M shares), BlackRock Inc. (5.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.84M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2.95M shares), GILDER GAGNON HOWE & CO LLC (2.4M shares), Artisan Partners Limited Partnership (2.05M shares), Neuberger Berman Group LLC (1.85M shares), and Senator Investment Group LP (1.75M shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.